Cipher Pharmaceuticals Inc
TSX:CPH

Watchlist Manager
Cipher Pharmaceuticals Inc Logo
Cipher Pharmaceuticals Inc
TSX:CPH
Watchlist
Price: 12.48 CAD -0.08%
Market Cap: 319.6m CAD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+37%
Revenue
Forecast
+20%
Operating Income
Forecast
N/A
Net Income
Forecast
+16%

Wall Street
Price Targets

CPH Price Targets Summary
Cipher Pharmaceuticals Inc

Wall Street analysts forecast CPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPH is 17.05 CAD with a low forecast of 12.63 CAD and a high forecast of 22.05 CAD.

CPH Lowest Forecast
Wall Street Target
12.63 CAD
1% Upside
CPH Average Forecast
Wall Street Target
17.05 CAD
37% Upside
CPH Highest Forecast
Wall Street Target
22.05 CAD
77% Upside
Lowest
Price Target
12.63 CAD
1% Upside
Average
Price Target
17.05 CAD
37% Upside
Highest
Price Target
22.05 CAD
77% Upside
Cipher Pharmaceuticals Inc Competitors:
Price Targets
PHO
Photocure ASA
65% Upside
HIKAL
Hikal Ltd
10% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
9% Upside
A
APPH
Apontis Pharma AG
23% Upside
PHO
Photocure ASA
65% Upside
HIKAL
Hikal Ltd
10% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
9% Upside
A
APPH
Apontis Pharma AG
23% Upside
S
GPCR
Structure Therapeutics Inc
219% Upside

Revenue
Forecast

Revenue Estimate
Cipher Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Cipher Pharmaceuticals Inc's revenue is 1%. The projected CAGR for the next 3 years is 20%.

1%
Past Growth
20%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Cipher Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Cipher Pharmaceuticals Inc's operating income is -5%. The projected CAGR for the next 2 years is 68%.

-5%
Past Growth
68%
Estimated Growth
Estimates Accuracy
6%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Cipher Pharmaceuticals Inc

The compound annual growth rate of Cipher Pharmaceuticals Inc's net income for the next 3 years is 16%.

N/A
Past Growth
16%
Estimated Growth
Estimates Accuracy
5%
Average Beat
What are analyst estimates?

See Also

Summary
CPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
CPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CPH stock valuation using valuation multiples.
Wall Street Estimates
CPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CPH's stock price target?
Price Target
17.05 CAD

According to Wall Street analysts, the average 1-year price target for CPH is 17.05 CAD with a low forecast of 12.63 CAD and a high forecast of 22.05 CAD.

What is Cipher Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Cipher Pharmaceuticals Inc's revenue is 1%. The projected CAGR for the next 3 years is 20%.

What is Cipher Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
68%

For the last 8 years the compound annual growth rate for Cipher Pharmaceuticals Inc's operating income is -5%. The projected CAGR for the next 2 years is 68%.

What is Cipher Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
16%

The compound annual growth rate of Cipher Pharmaceuticals Inc's net income for the next 3 years is 16%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 255,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.